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Plants from Annona (Annonaceae) genus are present in tropical regions, where they have economic and 
medicinal potential. Information on the fatty acids profile and bioactivity from seed oil of Annona 
species are incipient. The objective of this work was to investigate Annona hypoglauca seeds oil in 
terms of its yield, composition and biological activity (acetylcholinesterase enzyme inhibition, 
bactericidal and fungicidal activity). Fatty acids profiles were determined by Gas Chromatography 
equipped with Flame Ionization Detector. Oil yield reached about 15% and the major constituents 
detected were ω-9 oleic acid (42.65%) and ω-6 linoleic acid (29.63%). A. hypoglauca oil was potent for 
acetylcholinesterase inhibition (79.55%), and presented high and selective bioactivity against Candida 
albicans. 
 





The Annonaceae family consists of about 112 genera and 
2,440 species (Couvreur et al., 2011), occurring in 
tropical regions. Brazil has 33 native genera with about 
250 species (Souza and Lorenzi, 2008). Species from 
Annona genus present various activities such as 
anthelmintic (Ferreira et al., 2013), antioxidant (Julián-
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Loaeza et al., 2011), antidiabetic (Florence et al., 2014), 
anticancer (Wang et al., 2014), antiacetylcholinesterase 
(Tsai and Lee, 2010), antimicrobial (Jamkhande et al., 
2014), among others. Activity has been reported for 
various parts of the plant such as roots (Jamkhande et 
al., 2014), stem bark (Dutra et al., 2014), leaves 
(Matsumoto et al., 2014), fruit pulp (Clerici and Carvalho-
Silva, 2011) and seeds (Ribeiro et al., 2014). A huge 
diversity of substances associated to a range of 
medicinal and nutritional (Pareek et al., 2011) benefits 
has also been described. 
Annona hypoglauca species has in extracts of its wood 
antitumor activity against breast adenocarcinoma has 
been described for A. hypoglauca (Suffredini et al., 2007). 
Other screenings have shown cytotoxic activity against 
tumor cell lines such as prostate, lung, colon, central 
nervous system, leukemia, among others (Rinaldi, 2007). 
Activity of A. hypoglauca against the bacterium 
Streptococcus mutans has also been reported (Barnabé 
et al., 2014). The information on biological activities of A. 
hypoglauca is incipient. This work was addressed to 
study A. hypoglauca seeds oil in terms of its yield, 
composition and biological activities, which included 
examination on whether acetylcholinesterase was 




MATERIALS AND METHODS 
 
Source and processing of A. hypoglauca seeds 
 
The plant was identified by Ricardo de Oliveira Perdiz (Studies 
Center of Amazonian Biodiversity, CENBAM, Brazil) and deposited 
in UFRR Herbarium (UFRR 3654). The fruits were obtained in 
Mucajaí city, Roraima, taken to the Environmental Chemistry 
Laboratory (Research Center, Post-Graduate Course in Science 
and Technology – NPPGCT-UFRR) and washed. Seeds were 
removed, washed, and dried at room temperature and then were 
placed in a drying oven at 40°C with air circulation. Seeds were 
ground and sieved on a 20 to 40 mesh fabric to obtain a 
homogeneous granulation (Jorge and Luzia, 2012).  
 
 
A. hypoglauca oil seeds processing 
 
The oil was obtained by extraction from hexane solvent in a Soxhlet 
apparatus for 6 h. The solvent was evaporated on rotaevaporator 
and the oil (10.0328 g) was properly packaged in an amber vial 




Hydrolysis and methylation of lipids 
 
An aliquot (10 mg) of A. hypoglauca oil was transferred to a 2 mL 
cryotube, which contained 100 μL of a mixture made of ethanol 
(95%) and KOH 1 mol/L (5%). After vortexing for 10 s, esters in the 
oil were hydrolyzed in a microwave oven (Panasonic Piccolo) at 80 
W (power 2) for 5 min. After cooling and neutralization with 400 μL 
of hydrochloric acid 20%, 20 mg NaCl and 600 μL of ethyl acetate 
were added. Afterwards, free fatty acids were obtained by using an 





Christie, 1989). Thus, after vortexing for 10 s and rest for 5 min, 
aliquots (300 μL) of the ethyl acetate layer was taken, placed in 
microcentrifuge tubes and dried by evaporation. Free fatty acids 
were methylated using 100 μL of BF3/methanol (14%) and the 
reaction mixture was heated for 10 min in a water-bath at 60°C. 
After dilution with 400 μL methanol, fatty acid methyl esters were 
analyzed by Gas Chromatography. 
 
 
Oil analysis by GC-FID 
 
Free fatty acids were resolved by Gas Chromatography using 
HP7820A (Agilent) system equipped with flame ionization detector. 
An Innowax column (HP) 15 m × 0.25 mm × 0.20 μm was used and 
the following temperature gradient: 100°C min and 0.7°C/min up to 
240°C; injector (1/30 split) to 250 and 260°C detector. Hydrogen 
was used as carrier gas (3 mL/min) and injection volume was 1 μL. 
The data acquisition program used was EZChrom Elite Compact 
(Agilent). The peaks were identified using FAME Mix C14-C22, 





AChE inhibition assay 
 
Aliquots of a working solution (25 µL) (sample in DMSO 10 mg/mL) 
were added to microplate wells and positive and negative controls 
were also prepared. To the first five wells of a column (positive 
control) 25 µL of an eserine solution prepared at 10 mg/mL (31 mM; 
2.7 mM in the whole reaction mixture 275 µL) in Tris/HCl at pH 8.0) 
was added. Then, 25 µL of acetylthiocholine iodide (ATChI, Sigma 
A5751) 15 mM; the reaction mixture, 125 µL of 5',5-dithio-bis (2-
nitrobenzoate) (DTNB, Sigma D8130) (3 mM) and 50 µL of Tris/HCl 
(50 mM, pH 8) containing 0.1% (m/v) bovine serum albumin was 
added to each well. Absorbance was measured at 405 nm every 1 
min for 8 times. Then 25 µL (0.226 U/mL) of Electric eel AChE (type 
VI-S) provided by Sigma (C3389-500UN) in Tris/HCl was added to 
each well. Absorbance was measured at 405 nm by 10 times (Frank 
and Gupta, 2005; Ellman et al., 1961). 
 
 
Filamentous fungi assay 
 
Filamentous fungi used in this test were Aspergillus flavus (CCT 
4952) and Fusarium proliferatum (CML 3287). DMSO was used for 
sample preparation and the concentration of sample in the assay 
was 250 mg/mL. Sabouraud broth was used for fungal growth. A 
spore suspension at a concentration of 5 × 10
-5
 spores/mL was 
used after spores counting on a Neubauer chamber. The sample 
incubation time was 48 h after which absorbance was read at 490 
nm on a microtitre plate reader. Data were processed using the 
Outlier method, Grubbs test with 95% significance level. The 
percentage of inhibition was calculated by using the formula. 
 
% inhibition = 100-AC-AC × 100AH-AM 
 
AC = absorbance of the sample; AC = absorbance of control 
sample; AH = absorbance of microorganisms control and AM = 
absorbance culture medium control. 
 
 
Antibacterial and antifungal assay 
 
Escherichia coli (ATCC 25922), Salmonella tiphymurium (ATCC 
14028), Staphylococcus aureus (ATCC 25923) and Streptococcus 
sanguinis (ATCC 49456) and Candida albicans (ATCC 18804) were 
used in the assay following the procedures for Minimum Inhibitory














Zarrabal et al., 2014) 
Corn (Carvajal-
Zarrabal et al., 2014) 
Canola (Carvajal-
Zarrabal et al., 2014) 
Lauric acid (C12:0) 1.56 0.09 0 0 0 
Myristic acid (C14:0) 2.86 0.13 0 0 0 
Palmitic acid (C16:0) 4.74 16.35 11.32 7.19 7.50 
Palmitoleic acid (C16:1) 4.90 0.55 0.11 0.02 0.20 
Stearic acid (C18:0) 6.87 6.65 4.34 4.51 3.30 
Oleic acid (ω-9) (C18:1) 7.07 42.65 74.12 32.08 32.0 
Linoleic acid (ω-6) (C18:2) 7.56 29.63 7.64 54.26 37.0 
α-Linolenic acid (ω-3) (C18:3) 8.20 0.65 0.61 0.10 7.70 
Eicosanoic acid (C20:0) 8.98 0.50 0 0 0 




Concentration (MIC) described below. Concentrations assayed 
were 500, 250, 125, 62.5, 31.25, 15.6, and 3.9 µg/mL (Zacchino 
and Gupta, 2007). Samples were weighed and dissolved in DMSO 
to 50 mg/mL. Forty µL of this solution was added to a flask 
containing 960 µL of BHI (Brain Heart Infusion) broth (working 
solution). A pre-inoculum was prepared in which the bacteria and 
the yeast, stored under refrigeration, were transferred with a 
platinum loop to test tubes containing 3 mL of freshly made BHI 
broth. The tubes were incubated at 37°C for 18 h. Then, the pre-
inoculum (500 µL) was transferred to tubes containing 4.5 mL of 
sterile distilled water. The tubes were homogenized and the 
concentration adjusted to 0.5 of McFarland turbidity standard (10
8
 
CFU/mL), thereby obtaining the inocula used in the bioassays. 
Assays were performed in 96-microwell plates in duplicate. One 
hundred µL of BHI broth was added to each well. In the first well 
100 µL of working solution was also added. The solution was 
homogenized and 100 µL transferred to the next well and so on 
until the last well, from where 100 µL was discarded. Then, 100 µL 
of microorganism inocula was added to wells. Eight different 
concentrations of each sample were tested. A positive control 
devoid of the working solution allowed us to examine 
microorganism growth. A negative control, which lacked the 
inoculum permitted us to discount the color coming from the 
working solution. A control plate containing 100 µL of BHI culture 
medium and 100 µL of sterile distilled water were added to the 
experiment as a control of BHI broth sterility. Microorganism growth 
was measured in ELISA plate reader (492 nm) immediately after 
ending the experiment (0 h). They were incubated at 37°C and read 
again after 24 h of experiments, ending the test. 
 
 
RESULTS AND DISCUSSION 
 
Fatty acids profile and quantification by gas 
chromatography using flame ionization detector (GC-
FID) 
 
Extraction of A. hypoglauca seeds provided 15.05% yield 
in oil. This oil was subjected to hydrolysis and methylation 
before being analyzed by GC-FID. Table 1 shows the 
identified fatty acids (%) from seed oil of A. hypoglauca. 
The relative abundance of fatty acids in seeds of other 
oil-making plants is also shown. The ω-9 in A. 
hypoglauca is higher than the corn oil and canola and ω-
6 higher than the olive oil and ω-3 was similar to the 
concentration in olive oil and superior to the corn oil, 
canola was superior. These unsaturated fatty acids are 
important to human health, because they act on reducing 
blood lipid, cholesterol, but the human body does not 




Bioactivity of A. hypoglauca 
 
Inhibition of acetylcholinesterase 
 
But fatty acids can go beyond reducing blood lipids and 
reduce cardiovascular problems. The fatty acids present 
in vegetable oils or fish fats may have anti-inflammatory 
activities (Calder, 2005; Calder, 1998; Zhao et al., 2005), 
mainly against neuroinflammation. The neuroinflam-
mation can lead to brain disorders such as Alzheimer's 
disease (AD) and Parkinson's disease, but there is a 
relationship between the use of polyunsaturated fatty 
acids present in oils or fats at low risk of developing these 
disorders (Bazinet and Layé, 2014). Thus, seek for new 
therapeutic agents from natural products such as 
extracts, essential oils and fixed oils with potential for 
inhibition of acetylcholinesterase (AChE) to treat people 
with AD is a modern challenge (Mukherjee et al., 2007). 
In this way, in testing the capacity of AChE inhibition, A. 
hypoglauca seed oil showed to be able to inhibit 79.55% 
of AChE activity. According to Vinutha et al. (2007) 
inhibitions values higher than 50% indicate potent 
inhibition; agents providing values below 30% are 
considered weak inhibitors and those leading to 30 to 
50% inhibition are considered moderate inhibitors. The 
best known and prevailing neurodegenerative diseases 
are Parkinson and Alzheimer (AD). Symptoms of the 
latter include a regression of various physiological func-
tions, causing  difficulties  in  language, memory, emotional 




Table 2. Bioactivity of oil from A. hypoglauca seeds against fungi and bacteria. 
 
% Oil inhibition against yeast 
Concentration (µg mL
-1
) C. albicans Miconazole (%) Nystatin (%)  
500 91.08 92.33 93.30  
250 90.61 91.05 90.77  
125 91.01 90.71 90.14  
62.5 90.02 90.55 90.18  
31.25 91.09 91.15 90.92  
15.625 94.57 91.61 91.49  
9.375 91.45 91.52 91.26  
3.90625 91.27 91.28 91.42  
     
% Oil Inhibition against filamentous fungi 
Concentration (µg mL
-1
) A. flavus F. proliferatum   
250 11.69% 3.69%   
     
% Oil inhibition against bacteria gram(-) 
Concentration (µg mL
-1
) E. coli Ampicillin (%) S. S. Typhimurium Ampicillin (%) 
500 30.867 100.0 77.637 100.0 
250 21.169 100.0 7.234 100.0 
125 17.737 100.0 24.939 100.0 
62.5 15.499 100.0 59.829 100.0 
31.25 16.792 96.270 57.241 100.0 
15.625 18.781 95.375 17.277 100.0 
9.375 22.910 94.529 56.930 100.0 
3.90625 26.789 79.559 63.763 100.0 
 
% Oil inhibition against bacteria gram(+) 
Concentration (µg mL
-1
) S. aureus Ampicillin (%) S. sanguinis Ampicillin (%) 
500 24.902 100.0 17.658 100.0 
250 28.937 100.0 14.117 3.223 
125 23.917 100.0 19.110 2678 
62.5 20.177 100.0 14.389 0.000 
31.25 12.106 100.0 7.490 0.000 
15.625 8.268 86.713 18.021 0.000 
9.375 13.780 34.744 20.835 0.000 




or personality behavior, and cognitive abilities (Singh et 
al., 2013). Since the number of people afflicted of AD 
increases exponentially, it is estimated that in 2050 about 
115 million people might be affected by AD around the 
world (WHO, 2012). 
 
 
Bioassays with filamentous fungi 
 
A. hypoglauca oil showed low inhibition of fungi viability 
(A. flavus, 11.69%; and F. proliferatum, 3.69%, Table 2). 
These unsatisfactory results discarded the use of the oil 
as a means to control these filamentous fungi. A. flavus 
and F. proliferatum are phytopathogenic fungi that 
generate large economic damage. For A. flavus, for 
example, various types of grains contaminated with the 
mycotoxin aflatoxin lead to asperlogilosis in humans with 
severe effects on the respiratory tract (Hedayati et al., 
2007). In turn, F. proliferatum can produce rot in some 
crops, such as corn on the cob; more recently, it has 
been reported that the fungus causes rot of soybean root 
(Chang et al., 2015). 
 
 
Bioassay with C. albicans 
 
When testing the capacity of A. hypoglauca seeds oil 





(Table 2). In some concentrations, oil from seeds of A. 
hypoglauca was superior to the inhibition promoted by 
the standard utilized. It is worth noting that inhibition 
caused by the oil was greater than 94% in the 
concentration of 15.625 mg/L, while at the same 
concentration miconazole and nystatin only reached 92% 
inhibition (Table 2). C. albicans is an opportunistic 
pathogen host in humans. The patient may even need to 
be hospitalized because of C. albicans infection called 
candidemia. People with low immunity, the elderly, 
patients with cancer, diabetes, surgery, among, others, 




Bioassays with bacteria  
 
The antibacterial activity test using the A. hypoglauca 
seed oil against E. coli, S. tiphymurium, S. aureus, S. 
sanguinis and C. albicans showed notable inhibition, 
except for E. coli which was poorly inhibited: 31% with 
500 mg L
-1
 oil and 27% with 3.90625 mg L
-1
. The 
antibacterial activity against S. typhimurium was greater. 
Using 500 mg L
-1
 of seed oil the inhibition extent reached 
78% and at the lowest concentration tested (3.90625 mg 
L
-1
) the inhibition level was rather high (64%). E. coli and 
S. typhimurium are Gram(-) bacteria that may cause 
diarrhea, intense fever and even death. They are 
transmitted principally by fecal-oral contamination, very 
common in countries without basic sanitation, as well as 
the improper handling of food (Moura et al., 2012; Butler, 
2011). The activity of the oil against S. aureus was not 
satisfactory, since less than 30% inhibition was observed 
at all concentrations used. Similarly, S. sanguinis inhibition 
was below 40% at all concentrations. The low inhibition of 
A. hypoglauca seed oil towards some bacterial strains 
and high inhibition against C. albicans is indicative of a 
selective action mechanism, which deserves further 
investigation. S. aureus and S. sanguinis are Gram(+) 
bacteria which also cause grave health problems for 
humans, for instance skin infections and pneumonia (S. 
aureus), periodontal disease and severe endocarditis (S. 
sanguinis) (Evans et al., 2014; Sung et al., 2008). The 
WHO (World Health Organization) (2014) pointed out that 
there is global concern about the indiscriminate use of 
antibiotics, because this makes it that fungi and bacteria 
develop resistance to current drugs. Thus, it is necessary 





The oil from A. hypoglauca seed can be considered as an 
alternative source of vegetable oil. It can be used as raw 
material in the pharmaceutical and food industries, as it is 
constituted by essential fatty acids, where ω-9 and ω-6 
unsaturated fatty acids occur in high proportion. Of note 
was   the   potent  inhibition  that the oil exerted on AChE, 




about 80% of the activity was suppressed. Although the 
bioactivity against filamentous fungi (A. flavus and F. 
proliferatum) was low, it was excellent for inhibiting the 
yeast C. albicans, exceeding 90%. At some concen-
trations, the activity of the oil was superior to that 
displayed by clinically used standards. The inhibition level 
did not reach 50% against E. coli and was above 77% for 
S. tiphymurium. The inhibition of Gram-positive bacteria, 
S. aureus and S. sanguinis was unsatisfactory. The 
excellent bioactivity of the oil against C. albicans may be 
related to selectivity and this is the most outstanding 
action detected for this oil. 
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